Vext Science Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Vext Science Inc cash flow conversion efficiency. Based on the latest financial reports, Vext Science Inc (VV5) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.26 Million ≈ $1.47 Million USD) by net assets (€68.41 Million ≈ $79.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vext Science Inc (2017–2024)

Cash flow conversion efficiency of Vext Science Inc from 2017 to 2024. This chart illustrates how Vext Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Vext Science Inc (VV5) stock price for real-time trading data and today's change.

Vext Science Inc Cash Flow Conversion Ratio Explained

Vext Science Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vext Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vext Science Inc ranked by their cash flow conversion efficiency. Also see VV5 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
MFS Investment Grade Municipal Trust
NYSE:CXH
0.023x
Comms Group Ltd
AU:CCG
0.068x
Level Biotechnology
TWO:3118
0.021x
KMH Hitech Co. Ltd
KQ:052900
-0.014x
Foamit Oyj
HE:FOAMIT
0.050x
Dunia Virtual Online Tbk Pt
JK:AREA
0.063x
Hammer Metals Limited
F:6HM
-0.006x
NU World Holdings Ltd
JSE:NWL
-0.049x

Annual Cash Flow Conversion Efficiency for Vext Science Inc (2017–2024)

The table below shows the annual cash flow conversion efficiency of Vext Science Inc from 2017 to 2024. Review Vext Science Inc (VV5) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €75.74 Million
≈ $88.54 Million
€3.29 Million
≈ $3.84 Million
0.043x -6.79%
2023-12-31 €94.98 Million
≈ $111.04 Million
€4.42 Million
≈ $5.17 Million
0.047x -43.43%
2022-12-31 €71.92 Million
≈ $84.08 Million
€5.92 Million
≈ $6.92 Million
0.082x -58.13%
2021-12-31 €59.39 Million
≈ $69.44 Million
€11.68 Million
≈ $13.66 Million
0.197x +130.49%
2020-12-31 €36.31 Million
≈ $42.45 Million
€3.10 Million
≈ $3.62 Million
0.085x +656.98%
2019-12-31 €25.67 Million
≈ $30.01 Million
€-393.31K
≈ $-459.82K
-0.015x -110.81%
2018-12-31 €17.00 Million
≈ $19.88 Million
€2.41 Million
≈ $2.82 Million
0.142x -33.46%
2017-12-31 €8.77 Million
≈ $10.26 Million
€1.87 Million
≈ $2.19 Million
0.213x --

About Vext Science Inc

F:VV5 Germany Drug Manufacturers - Specialty & Generic
Market Cap
$31.28 Million
€26.75 Million EUR
Market Cap Rank
#23425 Global
#2049 in Germany
Share Price
€0.14
Change (1 day)
+2.13%
52-Week Range
€0.06 - €0.21
All Time High
€1.26
About

Vext Science, Inc., through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. The company al… Read more